Details of the Drug Combination

General Information of Drug Combination (ID: DC2A4BK)

• Drug Combination Name: GALE-302 + GALE-301
• Indication: Ovarian cancer; Status: Phase 1 [1]
• Component Drugs:
  GALE-302 (DM4WTRZ): N.A.
  GALE-301 (DMNEM46): N.A.

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [3] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035004)